4.5 Article

Measuring brain atrophy with a generalized formulation of the boundary shift integral

期刊

NEUROBIOLOGY OF AGING
卷 36, 期 -, 页码 S81-S90

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.04.035

关键词

boundary shift integral; Alzheimer's disease; Clinical trials; MRI; Biomarker

资金

  1. National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative)
  2. EPSRC [EP/H046410/1, EP/J020990/1, EP/K005278]
  3. MRC [MR/J01107X/1]
  4. NIHR Biomedical Research Unit (Dementia) at UCL
  5. NIHR BRC UCLH/UCL
  6. Brain Research Trust
  7. UCL Leonard Wolfson Experimental Neurology Centre
  8. Medical Research Council
  9. ADNI
  10. Multiple Sclerosis Society of Great Britain
  11. Nothern Ireland
  12. Alzheimer's Research UK
  13. Wolfson Foundation
  14. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  15. National Institute on Aging
  16. National Institute of Biomedical Imaging and Bioengineering
  17. Alzheimer's Association
  18. Alzheimer's Drug Discovery Foundation
  19. BioClinica, Inc.
  20. Biogen Idec Inc.
  21. Bristol-Myers Squibb Company
  22. Eisai Inc.
  23. Elan Pharmaceuticals, Inc.
  24. Eli Lilly and Company
  25. F. Hoffmann-La Roche Ltd.
  26. Genentech, Inc.
  27. GE Healthcare
  28. Innogenetics, N.V.
  29. IXICO Ltd.
  30. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  31. Johnson & Johnson Pharmaceutical Research & Development LLC.
  32. Medpace, Inc.
  33. Merck Co., Inc.
  34. Meso Scale Diagnostics, LLC.
  35. NeuroRx Research
  36. Novartis Pharmaceuticals Corporation
  37. Pfizer Inc.
  38. Piramal Imaging
  39. Servier
  40. Synarc Inc.
  41. Takeda Pharmaceutical Company
  42. Canadian Institutes of Health Research
  43. NIH [P30 AG010129, K01 AG030514]
  44. Engineering and Physical Sciences Research Council [EP/H046410/1, EP/J020990/1] Funding Source: researchfish
  45. National Institute for Health Research [NF-SI-0508-10123, NF-SI-0513-10134] Funding Source: researchfish
  46. Sparks Charity [09UCL04] Funding Source: researchfish
  47. NATIONAL INSTITUTE ON AGING [U01AG024904, P30AG010129, K01AG030514] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Brain atrophy measured using structural magnetic resonance imaging (MRI) has been widely used as an imaging biomarker for disease diagnosis and tracking of pathologic progression in neurodegenerative diseases. In this work, we present a generalized and extended formulation of the boundary shift integral (gBSI) using probabilistic segmentations to estimate anatomic changes between 2 time points. This method adaptively estimates a non-binary exclusive OR region of interest from probabilistic brain segmentations of the baseline and repeat scans to better localize and capture the brain atrophy. We evaluate the proposed method by comparing the sample size requirements for a hypothetical clinical trial of Alzheimer's disease to that needed for the current implementation of BSI as well as a fuzzy implementation of BSI. The gBSI method results in a modest but reduced sample size, providing increased sensitivity to disease changes through the use of the probabilistic exclusive OR region. (C) 2015 The Authors. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据